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rimary and a Half Prevention
an We Identify Asymptomatic
ubjects With High Vascular Risk?*
avid S. Celermajer, MB, BS, PHD, FRACP
ydney, Australia
e should be able to detect atherosclerosis early, before
linical events occur. After all, it is a disease process that
egins in childhood (1), takes many decades to progress in
ost subjects, and affects an organ (the vasculature) for
hich we have multiple diagnostic modalities available.
Nevertheless, we have not yet established a reliable
ethodology for seeing clearly through this long presymp-
omatic window of atherosclerotic disease. This failure is
robably because the pathogenesis of the disease is very
omplex, involving a plethora of contributing moieties
lipoproteins, a variety of cells, extracellular matrix, oxi-
ants, cytokines and thrombomodulators, among others)
nd because much of the disease processes occur inside the
essel wall, rather than adjacent to or within the lumen.
urthermore, there is only a loose association between the
urden of plaque and the risk of an event, with factors such
s vascular function, plaque composition, plaque geometry
nd remodeling, inflammation, and collateralization all
onfounding the relationships among plaque size, luminal
arrowing, and clinical events.
See pages 1980 and 1987
Preventive strategies for atherosclerosis often are divided
ather simplistically into “primary” and “secondary” preven-
ion, on the basis of the presence or absence of a prior
linical event. This dichotomy, however, does not empha-
ize identification of those asymptomatic individuals with
articularly high risk nor target such subjects for intensive
reventive therapy, that is, those who require “primary and
half” prevention. In this regard, novel blood tests and
maging modalities have been developed for these high-risk
symptomatic subjects that now might improve our diag-
ostic capabilities and therapeutic targeting strategies.
With such developments, preventive cardiology efforts
ay now move beyond the identification of epiphenomenal
risk factors,” to the measurement of processes more directly
elated to the pathology within the arterial wall (i.e., how
he risk factors have impacted on atherogenesis in a partic-
lar individual).
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.w
From the Department of Cardiology, Royal Prince Alfred Hospital and Faculty of
edicine, University of Sydney, Sydney, Australia.NFLAMMATORY MARKERS
number of large prospective population-based studies
ave established the potential importance of measuring
erum inflammatory markers as a means of identifying
igh-risk asymptomatic subjects. Of these, the high-
ensitivity C-reactive protein (hsCRP) measurement (2) is
he best studied to date. However, not all researchers agree
n the magnitude of risk conferred by an elevated hsCRP
evel (3), and further data are required concerning day-to-
ay variability in individual subjects as well as defining the
linical benefits that might accrue from treatment and risk
tratification according to hsCRP results. Nevertheless, this
s an exciting area in preventive medicine. Encouraging
ork also is now appearing about inflammatory markers
hat might be more specifically related to atherogenic
rocesses, such as lipoprotein-associated phospholipase A2,
lipoprotein-associated enzyme implicated in the vascular
nflammatory pathway leading to plaque formation (4).
ORONARY CALCIUM SCANNING
ascular imaging is an even more appealing concept for
dentification for high-risk subjects because it might provide
nformation about specific location of vulnerable plaque(s)
n addition to identifying vulnerable patients. The detection
f coronary artery calcium with fluoroscopy has long been
ecognized as valuable in predicting the presence of obstruc-
ive coronary artery disease, and it has been more than a
ecade since computed tomography scanning for quantifi-
ation of coronary calcium was popularized (5). This prom-
sing technique does appear to add extra diagnostic infor-
ation over and above the measurement of traditional risk
actors (6), and the absence of coronary calcium appears to
ave a high negative predictive value for subsequent events.
evertheless, some questions remain about lower specificity
han sensitivity, particularly in low-risk subjects, reproduc-
bility of measurements with serial studies, and aspects
elated to radiation and cost-effectiveness.
ASCULAR ULTRASONOGRAPHY
y contrast, ultrasonography is a very appealing technique
or studying atherosclerosis because it is noninvasive, rela-
ively inexpensive, widely available, simple, and generally
eproducible. Although the coronary arteries cannot be well
isualized by noninvasive ultrasonography, early changes in
eripheral arteries have been widely studied in the hope and
xpectation that this might provide useful insights into
resymptomatic atherosclerosis, given the systemic nature of
his disease. Furthermore, it became apparent more than a
ecade ago that ultrasonography was useful for the detection
f both early structural changes in the artery walls (such as
hickening or minor plaque), as well as early functional
hanges (such as loss of endothelium-dependent dilatation,
hich precedes plaque formation in high-risk subjects).
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June 21, 2005:1994–6 Editorial CommentThus, in 1992, we first described the technique of
ltrasonography-based measurement of flow-mediated di-
atation (FMD) in children and young adults at risk of
therosclerosis (7), which was later shown to be mediated
redominantly by endothelial nitric oxide release in re-
ponse to increased shear stress. This technique has been
sed by many research groups, who have documented a
elationship between FMD and most cardiovascular risk
actors in both low-risk and high-risk subjects. Recently,
everal centers have demonstrated a relationship between
ecreased brachial FMD and a higher incidence of cardio-
ascular events during follow-up (e.g., reference 8). Never-
heless, long-term prognostic data in a large population of
symptomatic subjects remain lacking.
At around the same time, Salonen et al. (9) reviewed the
ata concerning the measurement of intima-media thick-
ess (IMT) of the common carotid artery as an accurate and
eproducible measure of atherosclerosis. Carotid IMT has
een shown to correlate well with traditional risk factors and
urden of atheroma elsewhere in the body, and it also
ppears to be predictive of subsequent cardiovascular events
n large population studies. As with FMD, there is some
ariation in the protocols used for measurement carotid
MT, but most investigators have shown a significant
elationship between ultrasonography-based measurement
f this parameter and subsequent risk of events. Carotid
MT has now been used extensively as a surrogate endpoint
n disease reversibility trials.
MD, IMT, AND POPULATION SCREENING
hree recent studies have investigated the relationship
etween ultrasound-based measurements for vascular health
sing FMD and/or IMT and subsequent risk, two in this
ssue of the Journal (10,11) and one in a recent issue of
irculation (12).
In the larger of the two population-based ultrasound
tudies, Juonala et al. (12) studied the interrelations between
rachial endothelial function and carotid IMT in 2,109
ealthy adults ages 24 to 39 years, documenting a very
trong inverse association between FMD and IMT (p 
.001), in a multivariate model adjusted for traditional risk
actors. Furthermore, this inverse relationship was strongest
n subjects with intermediate or impaired FMD, suggesting
hat very good FMD might protect the vasculature from the
ropensity of risk factors to lead to structural wall thicken-
ng. This study encourages the use of both FMD and IMT,
n appropriately expert hands, for the identification of
igh-risk asymptomatic individuals.
In sharp contrast, the publication by the Firefighters And
heir Endothelium (FATE) investigators in this issue of
he Journal (10) found no significant relationship at all
etween carotid IMT and brachial artery FMD in 1,578
iddle-aged men without known cardiovascular disease.
lthough possible interpretations of these data include
naccuracies in the measurement techniques used or a lackf validity of carotid IMT and/or brachial FMD as good
easures of early vascular disease, the authors argue con-
incingly that carotid IMT and brachial artery FMD
robably provide complementary pathophysiologic insights
nto early atherosclerosis. Nevertheless, it is worrisome for
he potential applicability of both techniques that two large
opulation-based studies by highly experienced investiga-
ors have produced such strikingly discordant results.
In the third of these studies, Witte et al. (11) postulate,
n the basis of meta-analysis, that the association be-
ween FMD and cardiovascular risk may be limited to
ow-risk populations, in whom they document a signifi-
ant association between these parameters. However, it
hould be noted that the median sample size of the
eta-analyzed studies was only 20 subjects, that many of
he smaller studies recruited highly selected individuals
ather than population-based samples, and that the re-
ulting analysis will necessarily reflect the findings of the
argest studies included, as well as being potentially
onfounded by publication bias and the combination of
esults from studies which used very different methodol-
gies for the measurement of FMD. Thus, such findings
ould best be regarded as hypothesis-generating, rather as
definitive indication that FMD is best suited to risk
tratification in low-risk populations.
There is little doubt that the measurement of both FMD
nd IMT has provided an extremely valuable insight into
he relationship between risk factors and early arterial
isease, as well as important data concerning the effects of
reatment on early atherogenic processes. Large population
tudies support the predictive value of IMT, as do the only
rospective studies of FMD and event rates that have been
ublished to date, although as yet these have only been very
mall; thus, the final results of the FATE investigation
oncerning the predictive value of FMD for clinical events
re anxiously awaited. However, at the moment, the mea-
urement of FMD must be regarded as a valuable clinical
esearch tool but certainly not ready for “prime time,” for
opulation screening, or clinical decision-making.
Therefore, the quest for “the Holy Grail” of identification
f high-risk asymptomatic subjects continues. One feels,
owever, that the chalice is not far away, with blood tests
nd ultrasonography the most likely modalities to permit
ost-effective identification of vulnerable patients and ad-
anced imaging modalities more likely to allow localization
f vulnerable plaques.
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